Arcus Biosciences Inc (NYSE:RCUS)
$ 16.18 0.18 (1.13%) Market Cap: 1.47 Bil Enterprise Value: 472.16 Mil PE Ratio: 0 PB Ratio: 2.08 GF Score: 75/100

Arcus Biosciences Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 06:15PM GMT
Release Date Price: $35.64 (+10.07%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Okay. I guess, good morning or good afternoon, depending on where you're situated in the world. Welcome to Barclays Global Healthcare Conference. I'm Peter Lawson. I'm one of the biotech analysts at Barclays. Just wanted to thank everyone for taking time out of the day today. (Operator Instructions) And it gives me great pleasure to introduce management team from Arcus today.

So we've got of course, Terry Rosen, CEO; Bill Grossman, CMO; Juan Jaen, the President of Research. And we've also got Kaytee Bock as well from IR. So thank you so much for joining us.

Questions & Answers

Peter Richard Lawson;Terry J. Rosen
Barclays Bank PLC, Research Division - Research Analyst

I guess I'll kick it off just with a general question I've been asking all our companies just like -- I guess, over 200, 300 oncology companies out there. What's your point of differentiation you think the company has -- that Arcus has that others perhaps don't have or try to imitate?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot